APA (7th ed.) Citation

Rudakova, A. V., Gusev, D. A., Uskov, A. N., Konovalova, L. N., & Lobzin, Y. V. (2016). Сost-effectiveness of the second wave of protease inhibitors in the treatment of chronic hepatitis C (genotype 1) in patients not previously treated with antiviral drugs, and for relapsed disease. Journal Infectology.

Chicago Style (17th ed.) Citation

Rudakova, A. V., D. A. Gusev, A. N. Uskov, L. N. Konovalova, and Yu. V. Lobzin. Сost-effectiveness of the Second Wave of Protease Inhibitors in the Treatment of Chronic Hepatitis C (genotype 1) in Patients Not Previously Treated with Antiviral Drugs, and for Relapsed Disease. Journal Infectology, 2016.

MLA (9th ed.) Citation

Rudakova, A. V., et al. Сost-effectiveness of the Second Wave of Protease Inhibitors in the Treatment of Chronic Hepatitis C (genotype 1) in Patients Not Previously Treated with Antiviral Drugs, and for Relapsed Disease. Journal Infectology, 2016.